What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Livtencity (Maribavir)
Prescription Required
We don't have this generic product yet!
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
-
Product Details
Description
Your doctor may prescribe Livtencity prescription treatment specifically if you have undergone an organ transplant and are grappling with cytomegalovirus (CMV) infection due to immunosuppressive therapy.
Livtencity is a targeted therapy designed for cases where conventional treatments have proven ineffective in treating CMV infection. The drug works by binding to and inhibiting the protein kinase activity of the human CMV enzyme pUL97. This enzymatic inhibition curtails the replication of CMV viral particles.
Directions
Take two tablets by mouth twice daily (400 mg twice daily). Each tablet contains 200 mg of the active ingredient.
Ingredients
The active ingredient in Livtencity is maribavir.
Interactions
- Apalutamide
- Bexarotene
- Bosentan
- Carbamazepine
- CarBAMazepine
- Cenobamate
- CycloSPORINE (Systemic)
- Dabrafenib
- Dexamethasone?
- Digoxin
- Dipyrone
- Efavirenz
- Elagolix, estradiol, and norethindrone therapy pack?
- Encorafenib
- Enzalutamide
- Eslicarbazepine
- Etravirine
- Everolimus
- Fosphenytoin
- Fosphenytoin-Phenytoin
- Ganciclovir-Valganciclovir
- Lorlatinib
- Lumacaftor
- Lumacaftor-ivacaftor
- Mitapivat
- Mitotane
- Modafinil
- Nafcillin
- Pexidartinib
- Phenobarbital
- Phenytoin
- Primidone
- Rifabutin
- Rifampin (rifampicin)
- Rifapentine
- Rosuvastatin
- Sirolimus Products
- Sotorasib
- St John's Wort
- Tacrolimus (Systemic)
Cautions
Do not use Livtencity with ganciclovir or valganciclovir, as it may impede the efficacy of these drugs.
Your doctor should monitor levels of CMV DNA levels throughout treatment to assess potential viral resistance.
Since there are many potential drug interactions, patients are strongly encouraged to disclose their entire medication repertoire to healthcare professionals.
The safety profile of Livtencity in pregnant or breastfeeding patients remains uncertain, so it is advised to talk with your doctor before administration.
Initiating any new medications should be preceded by informed discussions with a qualified healthcare practitioner.
Livtencity is exclusively approved for usage in patients aged 12 years and older and those surpassing 35 kg in weight.
Side Effects
Common side effects of this drug include
- Diarrhea
- Fatigue
- Decreased hemoglobin
- Decreased neutrophils
- Decreased platelet count
- Infection
- Increased serum creatinine
- Nausea
- Taste disorder
- Vomiting
References
Livencity [package insert]. Lexington, MA: Takeda; November, 2021.
IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.Product Code : 13784
-
Product Reviews
